2022 Hybrid Research Symposium Posters
The 2022 NETRF Hybrid Research Symposium poster session was held at the Boston meeting for presenters that attended in-person, however, all posters were viewable online through the virtual Symposium platform.
Please note that some presenters chose not to post their presentations online following the meeting and have been respectfully omitted here.
Search by Session or by Name:
Select Session
Name
Update on Clinical Evaluation of 3-[18F]fluoro-p-hydroxyphenethylguanidine ([18F]3F-PHPG) for Localization of Paraganglioma and Pheochromocytoma using Positron Emission Tomography (PET)
Presenter: Raffel
SV2A PET Imaging for Noninvasive Assessment of Neuroendocrine Differentiation in Neuroendocrine Tumors
Presenter: Hao
Survival differences of lung neuroendocrine tumors in California by sociodemographic, clinicopathologic, and treatment factors
Presenter: Mulvey
Proximity to Healthcare Providers, Bankruptcy, and Relationship Status within Neuroendocrine Cancer Patients
Presenter: Skill
Patient-Derived Organoids and their Potential for Precision Medicine in Neuroendocrine Tumors
Presenter: Cortez
PAK4/NAMPT inhibitor KPT-9274 synergizes with Sunitinib in Pancreatic Neuroendocrine Tumor Cellular Models
Presenter: Uddin
Neuron-specific enolase� revisited: a new drug target in SDH-deficient paraganglioma?
Presenter: Tischler
Multiple endocrine neoplasia 4: genotype-phenotype association of germline CDKN1B variant type and site
Presenter: Halperin
Monitoring the treatment of AR42J tumor-bearing mice with 225Ac-Crown-TATE
Presenter: Wasylishen
Mapping the gut microbiome in patients with small intestinal neuroendocrine tumors
Presenter: Hofland
Loss of epigenetic repression of retrotransposons in pancreatic neuroendocrine tumors
Presenter: Senapati
Investigating the Role of Pseudohypoxia-related Metabolites in GEP-NET
Presenter: Tirosh
Image-guided delivery of temozolomide to SSTR2 expressing cells
Presenter: Aghaamiri
